These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 13410199)
21. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists. Mokler DJ; Commissaris RL; Warner MR; Rech RH J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557 [TBL] [Abstract][Full Text] [Related]
22. Differences in d-[3H]lysergic acid diethylamide binding in mouse cortex and hippocampus in vivo and in vitro revealed by radioautography and rapid filtration studies. Ebersole BJ; Weinstein H; Maayani S J Pharmacol Exp Ther; 1984 Jun; 229(3):865-71. PubMed ID: 6726661 [TBL] [Abstract][Full Text] [Related]
23. Quantitation of lysergic acid diethylamide in urine using atmospheric pressure matrix-assisted laser desorption/ionization ion trap mass spectrometry. Cui M; McCooeye MA; Fraser C; Mester Z Anal Chem; 2004 Dec; 76(23):7143-8. PubMed ID: 15571372 [TBL] [Abstract][Full Text] [Related]
25. Behaviorally inactive doses of mianserin antagonize the suppressant effect of lysergic acid diethylamide on a fixed-ratio operant. Dwoskin LP; Sparber SB J Pharmacol Exp Ther; 1983 Apr; 225(1):77-84. PubMed ID: 6834279 [TBL] [Abstract][Full Text] [Related]
26. On-line identification of lysergic acid diethylamide (LSD) in tablets using a combination of a sweeping technique and micellar electrokinetic chromatography/77 K fluorescence spectroscopy. Fang C; Liu JT; Lin CH Electrophoresis; 2003 Mar; 24(6):1025-30. PubMed ID: 12658691 [TBL] [Abstract][Full Text] [Related]
27. The pharmacology of mescaline and D-lysergic acid diethylamide (LSD). KOELLE GB N Engl J Med; 1958 Jan; 258(1):25-32. PubMed ID: 13493730 [No Abstract] [Full Text] [Related]
28. A method of estimating drug effects on central excitability of the Siamese fighting fish. TROUT DL Arch Int Pharmacodyn Ther; 1957 Aug; 111(3):334-41. PubMed ID: 13459518 [No Abstract] [Full Text] [Related]
29. Correction to: Intra-specific copy number variation of MHC class II genes in the Siamese fighting fish. Wong ATC; Lam DK; Poon ESK; Chan DTC; Sin SYW Immunogenetics; 2022 Aug; 74(4):443. PubMed ID: 35666272 [No Abstract] [Full Text] [Related]
30. Lysergic acid diethylamide (LSD-25). XXV. Effect of potassium cyanide and other oxidase and respiratory inhibitors on the Siamese fighting fish. WEISS B; ABRAMSON HA; BARON MO AMA Arch Neurol Psychiatry; 1958 Sep; 80(3):345-50. PubMed ID: 13570749 [No Abstract] [Full Text] [Related]
31. Defining the histamine H2-receptor in brain: the interaction with LSD. Green JP; Weinstein H; Maayani S NIDA Res Monogr; 1978; (22):38-59. PubMed ID: 30911 [TBL] [Abstract][Full Text] [Related]
32. Lysergic acid diethylamide (LSD-25) antagonists. I. Blocking effect of brain extract in the Siamese fighting fish; preliminary report. ABRAMSON HA; SKLAROFSKY B; BARON MO; GETTNER HH AMA Arch Neurol Psychiatry; 1957 Apr; 77(4):439-45. PubMed ID: 13410199 [No Abstract] [Full Text] [Related]